Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines

International Journal of Cancer

Volumn 70, Issue 5, 1997, Pages 582-586

  Straten, Per Thor ^a   Kirkin, Alexei F ^a   Seremet, Tina ^a   Zeuthen, Jesper ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; LMP1; LMP2; MESSENGER RNA; TRANSPORTER ASSOCIATED PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; TAP; TUMOR CELL LINE; TUMOR IMMUNITY;

AMINO ACID TRANSPORT SYSTEMS; ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; EXORIBONUCLEASES; FUNGAL PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MELANOMA; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0030891643     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970304)70:5<582::AID-IJC15>3.0.CO;2-F     Document Type: Article

References (23)

1. ALPAN, R.S., ZHAN, M. and PARDEE, A.B., Cell cycle dependent expres- sion of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell line. Cancer Res., 56, 4358-4361 (1996).
2. BECKER, J.C., CZERNY, C. and BRÖCKER, E.B., Maintenance of clonal anergy by endogenously produced IL-10. Int. immunol., 6, 1605-1612 (1994).
3. BELICH, M.P. and TROWSDALE, J., Proteasome and class I antigen processing and presentation. Mol. Biol. Rep., 21, 53-56 (1995).
4. BIRCK, A., Li, L., THOR STRATEN, P., SUGAR, J., HOU-JENSEN, K. and ZEUTHEN, J., Analysis of T-cell receptor AV and BV chain variable gene expression by infiltrating lymphocytes in Spitz and halo naevi. Melanoma Res. (1997) (in press).
5. BOON, T. and VAN DER BRUGGEN, P., Human tumor antigens recognized by T lymphocytes. J. exp. Med., 183, 725-729 (1996).
6. CROMME, F.V., AIREY, J., HEEMELS, M.T., PLOEGH, H.L., KEATING, P.J., STERN, P.L., MEIJER, C.J. and WALBOOMERS, J.M., Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. exp. Med., 179, 335-340 (1994a).
7. CROMME, F.V., VAN BOMMEL, P.F., WALBOOMERS, J.M., GALLEE, M.P., STERN, P.L., KENEMANS, P., HELMERHORST, T.J., STUKART, M.J. and MEIJER, C.J., Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Brit. J. Cancer, 69, 1176-1181 (1994b).
8. 2m gene expression. J. Clin. invest., 87, 284-292 (1991).
9. FERRONE, S. and MARINCOLA, F.M., Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clini- cal relevance. Immunol. Today, 16, 487-494 (1995).
10. GARRIDO, F., CABRERA, T., LOPEZ-NEVOT, M.A. and RUIZ-CABELLO, F., HLA class I antigens in human tumors. Adv. Cancer Res., 67, 155-195 (1995).
11. KAKLAMANIS, L., TOWNSEND, A., Doussis ANAGNOSTOPOULOU, I.A., MORTENSEN, N., HARRIS, A.L. and GATTER, K.C., Loss of major histocom- patibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Amer. J. Pathol, 145, 505-509 (1994).
12. KlRKIN, A., REICHERT PETERSEN, T., OLSEN, A.C., Li, L., THOR SlRATEN, P. and ZEUTHEN, J., Generation of human-melanoma specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol. Imnumother., 41, 71-81 (1995).
13. KIRKIN, A., THOR STRATEN, P. and ZEUTHEN, J., Differential modulation by Interferon gamma of the sensitivity of human melanoma cells to cytolytic T-cell clones that recognize differentiation or progression antigens. Cancer Immunol. Immunother., 42, 203-212 (1996).
14. MARINCOLA, F.M. and 12 OTHERS, Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol., 153, 1225-1237 (1994).
15. RESTIFO, N.P., ESQUIVEL, F., KAWAKAMI, Y., YEWDELL, J.W., MULÉ, J.J., ROSENBERG, S.A. and BENNINK, J.R., Identification of human cancers deficient in antigen processing. J. exp. Med., 177, 265-272 (1993).
16. 2-microglobulin in metastatic melanomas from five different patients receiving immuno therapy. J. nat. Cancer Inst., 88, 100-108 (1996).
17. SALVI, S., SEGALLA, F., RAO, S., ARIENTI, F, SARTORI, M., BRATINA, G., CARONNI, E., ANICHINI, A., CLEMENTE, C., PARMIANI, G. and SENSI, M., Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer Res., 55, 3374-3379 (1995).
18. SELIGER, B., HÖHNE, A., KNUTH, A., BERNHARD, H., EHRING, B., TAMPÉ, R. and HUBER, C., Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression. Clin. Cancer Res., 2, 1427-1433 (1996a).
19. SELIGER, B., HÖHNE, A., KNUTH, A., BERNHARD, H., MEYER, T., TAMPÉ, R., MOMBURG, F. and HUBER, C., Analysis of the major histocompatibility complex class I presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res., 56, 1756-1760 (1996b).
20. SENSI, M. and 14 OTHERS, Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/ MART-1. Proc. nat. Acad. Sci. (Wash.). 92, 5674-5678 (1995).
21. THOR STRATEN, P., BECKER, J.C., SEREMET, T., BRÖCKER, E.B. and ZEUTHEN, J., Clonal T-cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human melanoma. J. Clin. Invest., 98, 279-284 (1996).
22. THOR STRATEN, P., SCHOØLLER, J., HOU-JENSEN, K. and ZEUTHEN, J., Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas. Int. J. Cancer, 56, 78-86 (1994).
23. WRIGHT, K.L., WHITE, L.C., KELLY, A., BECK, S., TROWSDALE, J. and TING, J.P., Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J. exp. Med., 181, 1459-1471 (1995).